Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2017-10-01
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural Markers and Rehabilitation of Executive Functioning in Veterans With Traumatic Brain Injury and Posttraumatic Stress Disorder
NCT01410721
Combining Attention and Metacognitive Training to Improve Goal Directed Behavior in Veterans With TBI
NCT04044456
Remotely Deployed TBI Study
NCT01882244
Training in Goal-directed Attention Regulation for Individuals With Brain Injury
NCT01035606
Mild TBI Assessment & Rehabilitation
NCT02920788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One challenge in rehabilitation is that response to training can be highly variable, and a better understanding of the neural bases for this variability could inform patient care. Investigators have developed a system for training neurocognitive skills that can be used in rehabilitation neuroscience studies to elucidate the neural bases of improvements in cognitive functioning. The training system is designed to help patients improve goal-directed brain state regulation, and preliminary work has investigated brain network parameters that may predict response to training. Electroencephalography (EEG) potentially provides easily accessible markers for the neural bases of improvements with training.
Objectives in this pilot study are to investigate the potential of EEG markers to: (1) explain differential responses to attention regulation training; and (2) predict responses to training.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
State regulation skill training
This arm utilizes a training system designed to strengthen goal-directed cognitive-emotional state regulation skills. The emphasis is on practice and active application of skills across a range of challenge contexts. Digital scenarios provide experiential learning opportunities, allowing Veterans to apply skills to tackle challenges that are calibrated to maximize learning. Coaches guide learning for successful application of skills to challenges in personal life.
State regulation skill training
Participants complete seven supervised training sessions. Training sessions last 2 hours, and participants are requested to complete approximately 2.5 hours of additional skill practice over the course of each week outside of session (total \~4.5 hours per week).
Treatment-as-usual
In this arm, participants receive clinical care as usual in VA and other clinics.
Treatment-as-usual
Participants receive clinical care as usual over a matched time period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
State regulation skill training
Participants complete seven supervised training sessions. Training sessions last 2 hours, and participants are requested to complete approximately 2.5 hours of additional skill practice over the course of each week outside of session (total \~4.5 hours per week).
Treatment-as-usual
Participants receive clinical care as usual over a matched time period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of TBI (as defined by the American Congress of Rehabilitation Medicine and VA, with reported plausible mechanism of head injury, loss of consciousness with some period of posttraumatic alteration in cognition), in the chronic, stable phase of recovery (\>6 months from injury)
* On stable psychoactive medications (\> 30 days)
* Able and willing to participate in EEG, training and, assessments
Exclusion Criteria
* Severe cognitive dysfunction
* History of neurodevelopmental abnormalities
* Ongoing illicit drug or alcohol abuse
* Schizophrenia
* Bipolar disorder
* History of other neurological disorders
* Current medical illnesses that may alter mental status or disrupt participation in the study
* Active psychotropic medication changes
* There will be no restriction in regard to gender, race, and socioeconomic status
21 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Northern California Health Care System
FED
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anthony Chen, MD MA
Role: PRINCIPAL_INVESTIGATOR
VA Northern California Health Care System, Mather, CA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Northern California Health Care System, Mather, CA
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-12-00774
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
N2240-P
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.